Thomas, M., Schuler, M., Potzner, M., Szczudlo, T., Sutradhar, S., Yovine, A. and Wolf, J. (2015). Experience from the ASCEND-1 trial: Ceritinib in patients (Pts) with ALK-rearranged (ALK plus ) Non-Small Cell Lung Cancer (NSCLC) and brain metastases. Oncol. Res. Treat., 38. S. 270 - 271. BASEL: KARGER. ISSN 2296-5262

Full text not available from this repository.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Thomas, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schuler, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Potzner, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Szczudlo, T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sutradhar, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Yovine, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wolf, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-390929
Journal or Publication Title: Oncol. Res. Treat.
Volume: 38
Page Range: S. 270 - 271
Date: 2015
Publisher: KARGER
Place of Publication: BASEL
ISSN: 2296-5262
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
OncologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/39092

Downloads

Downloads per month over past year

Export

Actions (login required)

View Item View Item